Antioxidant properties of aminoguanidine

被引:64
作者
Courderot-Masuyer, C [1 ]
Dalloz, F [1 ]
Maupoil, V [1 ]
Rochette, L [1 ]
机构
[1] Fac Med & Pharm Dijon, LPPCE, F-21033 Dijon, France
关键词
aminoguanidine; antioxidant; free radicals; glycation;
D O I
10.1111/j.1472-8206.1999.tb00358.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
It is well known that aminoguanidine (AG) can diminish advanced glycosylation of proteins, which might be beneficial in preventing chronic diabetic complications. Recent reports suggested an inter-relationship between glycosylation of protein and free radical damage. In the present study, we examined the free radical scavenging properties of AG. Electron paramagnetic resonance using the spin-trap 5,5-dimethyl-1-pyrroline N-oxide (DMPO) was performed to determine the superoxide and hydroxyl radical scavenging abilities of AG. These experiments revealed that AG was an effective hydroxyl radical scavenger even though it expressed a direct inhibitory effect on the xanthine oxidase activity at high concentrations (AG greater than or equal to 5 mM). In the second part of the study, allophycocyanin was used as an indicator of free radical mediated protein damage. In the assay, 2,2'-azobis(2-amidinopropane) hydrochloride (AAPH) was used as a peroxyl radical generator, and the loss of allophycocyanin fluorescence was monitored. The antioxidant effect of AO was expressed in oxygen-radical absorbing capacity (ORAC), where one ORAC unit equals the net protection produced by 1 mu M Trolox (a water soluble analogue of vitamin E) as a control standard. AG exhibited a significant dose-dependent effect against free radical damage. These radical scavenging properties of AG may contribute to protective effects during glycation and explain the prevention of diabetic complications. (C) 1999 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:535 / 540
页数:6
相关论文
共 27 条
[1]   GLYCATION PRODUCTS AND THE PATHOGENESIS OF DIABETIC COMPLICATIONS [J].
BROWNLEE, M .
DIABETES CARE, 1992, 15 (12) :1835-1843
[2]   AMINOGUANIDINE PREVENTS DIABETES-INDUCED ARTERIAL-WALL PROTEIN CROSS-LINKING [J].
BROWNLEE, M ;
VLASSARA, H ;
KOONEY, A ;
ULRICH, P ;
CERAMI, A .
SCIENCE, 1986, 232 (4758) :1629-1632
[3]   ADVANCED GLYCOSYLATION ENDPRODUCTS - ROLE IN DIABETIC AND NONDIABETIC VASCULAR-DISEASE [J].
BUCALA, R ;
VLASSARA, H ;
CERAMI, A .
DRUG DEVELOPMENT RESEARCH, 1994, 32 (02) :77-89
[4]   OXYGEN-RADICAL ABSORBENCY CAPACITY ASSAY FOR ANTIOXIDANTS [J].
CAO, GH ;
ALESSIO, HM ;
CUTLER, RG .
FREE RADICAL BIOLOGY AND MEDICINE, 1993, 14 (03) :303-311
[5]   MECHANISTIC STUDIES OF ADVANCED GLYCOSYLATION END-PRODUCT INHIBITION BY AMINOGUANIDINE [J].
EDELSTEIN, D ;
BROWNLEE, M .
DIABETES, 1992, 41 (01) :26-29
[6]   Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation, and oxidant-induced apoptosis [J].
Giardino, I ;
Fard, AK ;
Hatchell, DL ;
Brownlee, M .
DIABETES, 1998, 47 (07) :1114-1120
[7]  
HALLIWELL B, 1992, J LAB CLIN MED, V119, P598
[8]   HYDROXYL RADICAL PRODUCTION AND AUTOXIDATIVE GLYCOSYLATION - GLUCOSE AUTOXIDATION AS THE CAUSE OF PROTEIN DAMAGE IN THE EXPERIMENTAL GLYCATION MODEL OF DIABETES-MELLITUS AND AGING [J].
HUNT, JV ;
DEAN, RT ;
WOLFF, SP .
BIOCHEMICAL JOURNAL, 1988, 256 (01) :205-212
[9]   INCREASE IN CARDIAC-MUSCLE FRUCTOSE CONTENT IN STREPTOZOTOCIN-INDUCED DIABETIC RATS [J].
KASHIWAGI, A ;
OBATA, T ;
SUZAKI, M ;
TAKAGI, Y ;
KIDA, Y ;
OGAWA, T ;
TANAKA, Y ;
ASAHINA, T ;
IKEBUCHI, M ;
SAEKI, Y ;
KIKKAWA, R ;
SHIGETA, Y .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1992, 41 (10) :1041-1046
[10]  
KOBAYASHI K, 1993, LIFE SCI, V53, P291